Business
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
• Support from The Michael J. Fox Foundation for Parkinson’s Research to advance critical research into Parkinson’s disease biology • Nautilus’ development of a single-molecule assay for measuring alpha-synuclein proteoforms is its latest application of Iterative Mapping method to uncover new biological insights• Weill Cornell Medicine-Qatar’s deep chemical biology and neurology expertise and field-leading protein standards and affinity reagents position the organizations to probe disease-associ
About this update from Nautilus Biotechnology, Inc.
[{"type":"image","alt":"Nautilus Biotechnology Inc.","displaySize":"","headline":null,"caption":"Nautilus Biotechnology Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":95,"url":"https://media.zenfs.com/en/globenewswire.com/22bec2aa5e570b0579f33fbb9cc54864"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gZG4ft0bTsyv782wsqtQmA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/22bec2aa5e570b0579f33fbb9cc54864","width":300,"height":95}},"lazy":false},{"type":"text","content":"• Support from The Michael J. Fox Foundation for Parkinson’s Research to advance critical research into Parkinson’s disease biology • Nautilus’ development of a single-molecule assay for measuring alpha-synuclein proteoforms is its latest application of Iterative Mapping method to uncover new biological insights• Weill Cornell Medicine-Qatar’s deep chemical biology and neurology expertise and field-leading protein standards and affinity reagents position the organizations to probe disease-associated proteoforms at unprecedented resolution","length":551,"tagName":"p"},{"type":"text","content":"SEATTLE and DOHA, Qatar, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering single-molecule proteome analysis; Weill Cornell Medicine-Qatar (WCM-Q); and The Michael J. Fox Foundation for Parkinson’s Research (MJFF) today announced a research collaboration to study the connection between the alpha-synuclein (aSyn) protein and Parkinson’s disease (PD). Supported by a $1.6 million research grant from MJFF, the high-impact project combines the Lashuel lab’s expertise in the molecular and chemical biology of neurodegeneration with Nautilus’ next-generation platform for measuring proteins and their functional variants, called proteoforms, at single-molecule resolution.","length":720,"tagName":"p"},{"type":"text","content":"Understanding the many forms and modifications of alpha-synuclein is a key priority for MJFF, as these differences may improve our understanding of PD biology and variability across individuals. Through its discovery and biomarker research efforts, the Foundation supports innovative technologies to better characterize alpha-synuclein proteoforms and related pathways, with the aim of generating insights that can inform future clinical researc...